PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Raltegravir
Presentation Product Chemical substance Chapter Items dispensed
Raltegravir 400mg tablets
0503010AEAAAAAA
Raltegravir Raltegravir Infections 9
Raltegravir 600mg tablets
0503010AEAAAEAE
Raltegravir Raltegravir Infections 1
Isentress 100mg chewable tablets
0503010AEBBABAB
Isentress Raltegravir Infections No data available
Isentress 100mg granules for oral suspension sachets
0503010AEBBADAD
Isentress Raltegravir Infections No data available
Isentress 25mg chewable tablets
0503010AEBBACAC
Isentress Raltegravir Infections No data available
Isentress 400mg tablets
0503010AEBBAAAA
Isentress Raltegravir Infections No data available
Isentress 600mg tablets
0503010AEBBAEAE
Isentress Raltegravir Infections No data available
Raltegravir 100mg chewable tablets
0503010AEAAABAB
Raltegravir Raltegravir Infections No data available
Raltegravir 100mg granules for oral suspension sachets
0503010AEAAADAD
Raltegravir Raltegravir Infections No data available
Raltegravir 25mg chewable tablets
0503010AEAAACAC
Raltegravir Raltegravir Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.